GlaxoSmithKline PLC is putting its faith in two high-volume, lower-risk businesses, vaccines and consumer health care, to stabilize the company ahead of what are expected to be challenging years for its pharmaceutical business.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?